| Literature DB >> 30257473 |
Dorin Harpaz1,2,3, Loo Pin Yeo4, Francesca Cecchini5, Trish H P Koon6,7, Ariel Kushmaro8,9,10, Alfred I Y Tok11,12, Robert S Marks13,14,15, Evgeni Eltzov16.
Abstract
Artificial sweeteners have become increasingly controversial due to their questionable influence on consumers' health. They are introduced in most foods and many consume this added ingredient without their knowledge. Currently, there is still no consensus regarding the health consequences of artificial sweeteners intake as they have not been fully investigated. Consumption of artificial sweeteners has been linked with adverse effects such as cancer, weight gain, metabolic disorders, type-2 diabetes and alteration of gut microbiota activity. Moreover, artificial sweeteners have been identified as emerging environmental pollutants, and can be found in receiving waters, i.e., surface waters, groundwater aquifers and drinking waters. In this study, the relative toxicity of six FDA-approved artificial sweeteners (aspartame, sucralose, saccharine, neotame, advantame and acesulfame potassium-k (ace-k)) and that of ten sport supplements containing these artificial sweeteners, were tested using genetically modified bioluminescent bacteria from E. coli. The bioluminescent bacteria, which luminesce when they detect toxicants, act as a sensing model representative of the complex microbial system. Both induced luminescent signals and bacterial growth were measured. Toxic effects were found when the bacteria were exposed to certain concentrations of the artificial sweeteners. In the bioluminescence activity assay, two toxicity response patterns were observed, namely, the induction and inhibition of the bioluminescent signal. An inhibition response pattern may be observed in the response of sucralose in all the tested strains: TV1061 (MLIC = 1 mg/mL), DPD2544 (MLIC = 50 mg/mL) and DPD2794 (MLIC = 100 mg/mL). It is also observed in neotame in the DPD2544 (MLIC = 2 mg/mL) strain. On the other hand, the induction response pattern may be observed in its response in saccharin in TV1061 (MLIndC = 5 mg/mL) and DPD2794 (MLIndC = 5 mg/mL) strains, aspartame in DPD2794 (MLIndC = 4 mg/mL) strain, and ace-k in DPD2794 (MLIndC = 10 mg/mL) strain. The results of this study may help in understanding the relative toxicity of artificial sweeteners on E. coli, a sensing model representative of the gut bacteria. Furthermore, the tested bioluminescent bacterial panel can potentially be used for detecting artificial sweeteners in the environment, using a specific mode-of-action pattern.Entities:
Keywords: artificial sweeteners; bioluminescent bacteria; environmental pollutants; gut microbiota; sport supplements; toxic effect
Mesh:
Substances:
Year: 2018 PMID: 30257473 PMCID: PMC6222326 DOI: 10.3390/molecules23102454
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Artificial sweeteners toxicity. The toxicity index of different artificial sweeteners on the three tested bioluminescent bacteria strains: (A) TV1061; (B) DPD2544; (C) DPD2794. A strong induction response pattern may be observed in the response of the TV1061 strain to saccharin and DPD2794 strain to aspartame and saccharin. In addition, a strong inhibition response pattern may be observed in the response of the TV1061 strain to sucralose.
Artificial sweeteners toxicity and viability effect (mg/mL).
| Strain | MLIC | MLIndC | MGIC | MGIndC | |
|---|---|---|---|---|---|
|
| TV1061 | N.E. | N.E. | N.E. | N.E. |
| DPD2544 | N.E. | N.E. | N.E. | N.E. | |
| DPD2794 | N.E. | 4 | N.E. | N.E. | |
|
| TV1061 | 1 | N.E. | 50 | N.E. |
| DPD2544 | 50 | N.E. | 50 | N.E. | |
| DPD2794 | 100 | N.E. | 50 | N.E. | |
|
| TV1061 | N.E. | 5 | 5 | N.E. |
| DPD2544 | N.E. | N.E. | N.E. | N.E. | |
| DPD2794 | N.E. | 5 | N.E. | N.E. | |
|
| TV1061 | N.E. | N.E. | N.E. | 2 |
| DPD2544 | N.E. | N.E. | N.E. | N.E. | |
| DPD2794 | N.E. | N.E. | N.E. | N.E. | |
|
| TV1061 | N.E. | 2 | N.E. | N.E. |
| DPD2544 | 2 | N.E. | N.E. | N.E. | |
| DPD2794 | N.E. | N.E. | N.E. | N.E. | |
|
| TV1061 | N.E. | N.E. | N.E. | N.E. |
| DPD2544 | N.E. | N.E. | N.E. | N.E. | |
| DPD2794 | N.E. | 10 | N.E. | N.E. |
MLIC—Minimum Luminescent Inhibition Concentration; MLIndC—Minimum Luminescent Induction Concentration; MGIC—Minimum Growth Inhibition Concentration; MGIndC—Minimum Growth Induction Concentration; N.E.—No Effect.
Sport supplements’ toxicity and viability effect (µg/mL).
| Strain | MLIC | MLIndC | MGIC | MGIndC | |
|---|---|---|---|---|---|
|
| TV1061 | N.E. | 2000 | N.E. | N.E. |
| DPD2544 | 2 × 10−3 | 2 × 10−6 | N.E. | N.E. | |
| DPD2794 | N.E. | N.E. | 2000 | N.E. | |
|
| TV1061 | N.E. | N.E. | N.E. | N.E. |
| DPD2544 | 1 × 10−3 | 1 × 10−6 | N.E. | N.E. | |
| DPD2794 | N.E. | N.E. | 1000 | N.E. | |
|
| TV1061 | N.E. | N.E. | N.E. | 4000 |
| DPD2544 | 4 × 10−3 | 4 × 10−6 | N.E. | N.E. | |
| DPD2794 | 4000 | N.E. | N.E. | 4000 | |
|
| TV1061 | N.E. | N.E. | N.E. | 5000 |
| DPD2544 | 5 × 10−3 | 5 × 10−6 | N.E. | N.E. | |
| DPD2794 | N.E. | N.E. | N.E. | 5000 | |
|
| TV1061 | N.E. | 5000 | N.E. | N.E. |
| DPD2544 | 5 × 10−3 | 5 × 10−6 | N.E. | N.E. | |
| DPD2794 | N.E. | 5000 | 5000 | N.E. | |
|
| TV1061 | N.E. | N.E. | N.E. | 3000 |
| DPD2544 | 3 × 10−3 | 3 × 10−6 | N.E. | N.E. | |
| DPD2794 | N.E. | N.E. | N.E. | N.E. | |
|
| TV1061 | 5000 | 500 | 5000 | N.E. |
| DPD2544 | 5 × 10−3 | 5 × 10−6 | N.E. | N.E. | |
| DPD2794 | 5000 | N.E. | 5000 | N.E. | |
|
| TV1061 | N.E. | N.E. | N.E. | 2000 |
| DPD2544 | 2 × 10−3 | 2 × 10−6 | N.E. | N.E. | |
| DPD2794 | N.E. | N.E. | N.E. | 2000 | |
|
| TV1061 | N.E. | 3000 | N.E. | N.E. |
| DPD2544 | 3 × 10−3 | 3 × 10−6 | N.E. | N.E. | |
| DPD2794 | N.E. | N.E. | N.E. | N.E. | |
|
| TV1061 | N.E. | N.E. | N.E. | 3000 |
| DPD2544 | 3 × 10−3 | 3 × 10−6 | N.E. | N.E. | |
| DPD2794 | N.E. | N.E. | N.E. | 3000 |
MLIC—Minimum Luminescent Inhibition Concentration; MLIndC—Minimum Luminescent Induction Concentration; MGIC—Minimum Growth Inhibition Concentration; MGIndC—Minimum Growth Induction Concentration; N.E.—No Effect.
Figure 2Sport supplements’ toxicity. Toxicity index of different sport supplements on the three tested bioluminescent bacteria strains: (A) TV1061; (B) DPD2544; (C) DPD2794.
Sport supplement profile.
| Artificial Sweeteners Content | Recommended Amount for Consumption | Ingredients | |
|---|---|---|---|
|
| Sucralose | 2 tablets (5 g), recommended to drink a lot of water | Creatine Hydrochloride, Cellulose, Dicalcium phosphate, Enteric Coating (Cellulose, Sodium Alginate, Medium Chain Triglycerides, Oleic and Stearic Acid), Natural Mint Flavor, Sucralose, Titanium Dioxide |
|
| Acesulfame Potassium-K and Sucralose | 2 (7 g) to 8 (28 g) scoops in 8–10 oz per serving (2 scoops) | Black Tea Extract, Green Tea Extract, Green Coffee Extract, Micronized Taurine, Micronized |
|
| Acesulfame Potassium-K and Sucralose | 1 (31 g) to 2 (62 g) scoops in 6–8 oz per scoop | Calcium, Cholesterol, Dietary Fibers, Potassium, Protein, Saturated Fat, Sodium, Sugars, Trans Fat |
|
| Sucralose | 1 (31 g) to 2 (62 g) scoops in 4–10 oz per scoop | Calcium, Cholesterol, proteins, Sodium, Saturated Fat, sugars, Trans Fat |
|
| Sucralose | 2 (9 g) to 6 (27 g) scoops in 10–12 oz per serving (2 scoops) | Caffeine, Green Tea Extract, Green Coffee Extract, Micronized Taurine, Micronized |
|
| Acesulfame Potassium-K | 1 (29.4 g) rounded scoop in 4–10 oz | Calcium, Protein, Saturated Fat, Sodium, Sugars, Trans Fat |
|
| Acesulfame Potassium-K and Sucralose | 1 (49 g) to 2 (98 g) scoops in 6 oz per scoop | Alpha lipoic acid, Calcium, Citric Acid, Creatine Monohydrate, Creatine HCI, Dicalcium Phosphate, Dextrose, |
|
| Acesulfame Potassium-K and Sucralose | 1 (34 g) scoop in 6 oz water or skim milk | Calcium, Cholesterol, Dietary Fiber, Iron, Protein, Saturated Fat, Sodium, Sugar |
|
| Acesulfame Potassium-K and Sucralose | 1 (32.4 g) to 2 (64.8 g) scoops in 8–12 oz | Calcium, Cholesterol, Dietary Fiber, Iron, Potassium, Protein, Saturated Fat, Sodium, Sugar, Trans Fat, Vitamin A, Vitamin C |
|
| Acesulfame Potassium-K and Sucralose | 1 (34.9 g) to 2 (69.8 g) scoops in 8–12 oz | Calcium, Cholesterol, Dietary Fiber, Iron, Multi-level Amino Acid Growth Matrix, Potassium, Protein, Saturated Fat, Sodium, Trans Fat |
Bioluminescent bacterial strains.
| Strain | Promoter | Plasmid | Stress Sensitivity | Reference | |
|---|---|---|---|---|---|
|
| RFM443 |
| pGrpELux5 | Heat Shock (Cytotoxic) | [ |
|
| W3110 |
| pFabALux6 | Fatty Acid Availability (Cytotoxic) | [ |
|
| RFM443 |
| pRecALux3 | SOS—DNA Damage (Genotoxicity) | [ |
Figure 3Experimental process. (A) each bacteria strain tested was striked on an agar plate containing Kanamycin, and incubated overnight at 37 °C; (B) a starter was grown from a single colony from the striked plate, and incubated overnight at 37 °C in a shaking incubator; (C) the starter was refreshed by adding 200 μL of the overnight culture into 10 mL of fresh LB, and then grown for 3–4 h at 30 °C in a non-shaking incubator; (D) the bacteria strains were then exposed to the different samples of different concentrations in a high-throughput measurement using a 96-well plate; (E,F) the toxicity (Relative Light Unit (RLU)) and growth (O.D. 600 nm) signals were measured continuously during the 16 h incubation at 26 °C, in the Luminometer and TECAN reader, respectively.